Edition:
United Kingdom

People: Catalyst Biosciences Inc (CBIO.OQ)

CBIO.OQ on NASDAQ Stock Exchange Capital Market

8.27USD
19 Jul 2019
Change (% chg)

$-0.18 (-2.13%)
Prev Close
$8.45
Open
$8.48
Day's High
$8.53
Day's Low
$8.26
Volume
16,990
Avg. Vol
55,398
52-wk High
$11.44
52-wk Low
$6.20

Landau, Jeffrey 

Mr. Jeffrey Landau is Vice President - Business Development of the Company. Mr. Landau previously served as Director of Corporate Development and Global Strategic Marketing at Threshold Pharmaceuticals since 2012 where he co-led various in-licensing and co-promotion deals. Prior to Threshold, Mr. Landau held increasingly senior global product strategy and new product planning positions at Onyx Pharmaceuticals, where he contributed significantly to global commercial strategy and development related to sorafenib, carfilzomib and regorafenib, all successful oncology products. Earlier in his career, he held various sales positions at Jazz Pharmaceuticals, Orphan Medical and Eli Lilly. Mr. Landau holds a B.S., Biotechnology/Biochemistry In Honors from the Virginia Polytechnic Institute and State University, and an M.B.A. from Stanford University Graduate School of Business.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --